Guidelines for Antiemetic Treatment of Chemotherapy-Induced Nausea and Vomiting: Past, Present, and Future Recommendations
Top Cited Papers
Open Access
- 1 September 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (9) , 1143-1150
- https://doi.org/10.1634/theoncologist.12-9-1143
Abstract
Learning Objectives: After completing this course, the reader will be able to: Explain the optimal antiemetic prophylaxis for patients receiving chemotherapy in regard to the emetogenic potential of the therapy.Describe the difference between acute and delayed emesis.Discuss the properties and optimal use of the different antiemetic drugs. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 28 references indexed in Scilit:
- A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group studySupportive Care in Cancer, 2007
- Emetic potential of daily oral etoposideSupportive Care in Cancer, 2006
- Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus ConferenceAnnals of Oncology, 2005
- A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group studySupportive Care in Cancer, 2005
- Antiemetic Efficacy of an Oral Suspension of Granisetron plus Dexamethasone and Influence of Quality of Life on Risk for Nausea and VomitingOncology Research and Treatment, 2005
- Anticipatory nausea and vomitingSupportive Care in Cancer, 2004
- Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an updateSupportive Care in Cancer, 2004
- Randomized, Double-Blind, Dose-Finding Study of Dexamethasone in Preventing Acute Emesis Induced by Anthracyclines, Carboplatin, or Cyclophosphamide:Journal of Clinical Oncology, 2004
- Delayed emesis: incidence, pattern, prognostic factors and optimal treatmentSupportive Care in Cancer, 2002
- Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patientsEuropean Journal Of Cancer, 1992